Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus

Published:2017-11-15 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Esaki Hiroki,Tachi Tomoya,Goto Chitoshi,Sugita Ikuto,Kanematsu Yuta,Yoshida Aki,Saito Kosuke,Noguchi Yoshihiro,Ohno Yuki,Aoyama Satoshi,Yasuda Masahiro,Mizui Takashi,Yamamura Masumi,Teramachi Hitomi

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study;Athyros;J. Clin. Pathol.,2004

2. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N. Engl. J. Med.,2001

3. Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency;Chan;Diabetes Obes. Metab.,2008

4. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality;Coresh;JAMA,2014

5. The influence of sex on renal function decline in people with Type 2 diabetes;de Hauteclocque;Diabet. Med.,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

2. Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users;Diabetes, Obesity and Metabolism;2024-07-31

3. Forty-three Years of Dedicated Efforts in Advancing Pharmacist Expertise: Aspiring to Become a Pharmacist and Cultivate Pharmacists Proficient in Recommending Prescription Medicines to Doctors;YAKUGAKU ZASSHI;2024-03-01

4. Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways;Frontiers in Pharmacology;2024-02-19

5. Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT;ACS Omega;2023-11-03